These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 1455413

  • 1. No increase of beta 2-glycoprotein I levels in patients with antiphospholipid antibodies.
    De Benedetti E, Reber G, Miescher PA, de Moerloose P.
    Thromb Haemost; 1992 Nov 10; 68(5):624. PubMed ID: 1455413
    [No Abstract] [Full Text] [Related]

  • 2. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov 10; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 3. Soluble CD154 plasma levels in patients with systemic lupus erythematosus: modulation by antiphospholipid antibodies.
    Ferro D, Pignatelli P, Loffredo L, Conti F, Valesini G, D'Angelo A, Violi F.
    Arthritis Rheum; 2004 May 10; 50(5):1693-4. PubMed ID: 15146442
    [No Abstract] [Full Text] [Related]

  • 4. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec 10; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 5. Serum apolipoprotein H levels in systemic lupus erythematosus are not influenced by antiphospholipid antibodies.
    Ichikawa Y, Takamatsu K, Shimizu H, Uchiyama M, Moriuchi J, Takaya M, Kobayashi N, Kawada T, Arimori S.
    Lupus; 1992 May 10; 1(3):145-9. PubMed ID: 1301975
    [Abstract] [Full Text] [Related]

  • 6. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A, Ruiz-Irastorza G, Egurbide MV, Garmendia M, Gabriel Erdozain J, Villar I, Aguirre C.
    Lupus; 2007 May 10; 16(10):810-6. PubMed ID: 17895304
    [Abstract] [Full Text] [Related]

  • 7. [Clinical significance of antiphospholipid antibodies].
    Atsumi T, Koike T.
    Rinsho Byori; 1998 Apr 10; 46(4):297-302. PubMed ID: 9594618
    [Abstract] [Full Text] [Related]

  • 8. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Apr 10; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 9. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A.
    J Rheumatol; 1997 Sep 10; 24(9):1710-5. PubMed ID: 9292792
    [Abstract] [Full Text] [Related]

  • 10. Antiphospholipid antibodies--our experience.
    Srikrishna A, Sitalakshmi S, Devi S, Damodar P, Varghese J, Suresh J, Mathew T.
    Indian J Pathol Microbiol; 2004 Apr 10; 47(2):174-7. PubMed ID: 16295461
    [Abstract] [Full Text] [Related]

  • 11. [The heterogeneity of systemic lupus erythematosus due to the antiphospholipid syndrome].
    Alekberova ZS, Nasonov EL, Stoianovich LZ.
    Ter Arkh; 1992 Apr 10; 64(5):77-9. PubMed ID: 1455383
    [No Abstract] [Full Text] [Related]

  • 12. Diagnosis of antiphospholipid antibodies.
    Petri M.
    Rheum Dis Clin North Am; 1994 May 10; 20(2):443-69. PubMed ID: 8016420
    [Abstract] [Full Text] [Related]

  • 13. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
    Tubach F, Hayem G, Marchand JL, Weber M, Palazzo E, de Bandt M, Roux S, Kahn MF, Meyer O.
    J Rheumatol; 2000 Jun 10; 27(6):1437-43. PubMed ID: 10852267
    [Abstract] [Full Text] [Related]

  • 14. Revision of the Sapporo criteria for the antiphospholipid syndrome-- coming to grips with evidence and Thomas Bayes?
    Lackner KJ, Peetz D, von Landenberg P.
    Thromb Haemost; 2006 Jun 10; 95(6):917-9. PubMed ID: 16732366
    [No Abstract] [Full Text] [Related]

  • 15. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Khamashta MA, Amengual O, Hughes GR.
    J Rheumatol; 1998 Jun 10; 25(6):1104-8. PubMed ID: 9632071
    [Abstract] [Full Text] [Related]

  • 16. Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies.
    Forastiero RR, Kordich L, Basilotta E, Carreras LO.
    Blood Coagul Fibrinolysis; 1994 Aug 10; 5(4):609-16. PubMed ID: 7841319
    [Abstract] [Full Text] [Related]

  • 17. Lupus anticoagulants and antiphospholipid antibodies monitoring in systemic lupus erythematosus.
    Ariano CC, Salmaggi A, Croci D, Lamperti E, Bottero P, Castiglione A, Venegoni E, La Mantia L, Eoli M.
    Contrib Nephrol; 1992 Aug 10; 99():118-22. PubMed ID: 1458916
    [No Abstract] [Full Text] [Related]

  • 18. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M, Duzgun N, Tunc SE, Tutkak H.
    Clin Biochem; 2007 May 10; 40(8):526-30. PubMed ID: 17359958
    [Abstract] [Full Text] [Related]

  • 19. IgM anti-β2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus.
    Mehrani T, Petri M.
    J Rheumatol; 2011 Mar 10; 38(3):450-3. PubMed ID: 21123325
    [Abstract] [Full Text] [Related]

  • 20. Why do patients with antiphospholipid antibody clot?
    Lockshin MD.
    Lupus; 1997 Mar 10; 6(4):351-2. PubMed ID: 9175018
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.